Immorna
PrivateLast Round
Grant
Aug 26, 2024
Total Funding Raised
$118.8M
Company Overview
Immorna is a biotechnology company that develops mRNA-based therapeutics and vaccines for cancer immunotherapy, infectious diseases, and rare genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immorna Comparables
Compare Immorna with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Suzhou CureMed Biopharma Technology Co., Ltd. | 88% | |
| Innorna | 87% | |
| Bristol Myers Squibb | 83% |
Immorna Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 26, 2024 | ||||
| Series A Extension | Feb 27, 2023 | ||||
| Series A | Jan 18, 2021 | ||||
| Seed | Dec 13, 2019 |
Immorna Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alwin Capital | Seed |
| China Chengtong Fund Management Co., Ltd. | Series A Extension |
| Zheshang Venture Capital | Series A Extension, Series A |
| Hillhouse Investment | Series A Extension |
| Co-Win Ventures | Series A Extension, Seed, Series A |
| Tigeryeah Capital | Series A Extension |
| Gates Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2024
Received $4M from the Bill & Melinda Gates Foundation.
- Feb 27, 2023
$100M round with participation from Xiamen C&D, Co-Win Ventures, and others.
Immorna Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Immorna's valuation, stock price, and market status.
Is Immorna a public or private company?
Immorna is a private company.
What is the current stock price of Immorna?
Immorna is a private company with no public stock price. No recent secondary market data is available.
How much is Immorna worth (valuation)?
Valuation information for Immorna is not publicly available.
Can I buy Immorna stock?
Immorna shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Immorna's last funding round?
Immorna's most recent funding round was Grant on August 26, 2024.
Who are the main investors in Immorna?
Key investors in Immorna include 华创资本.
Will Immorna IPO soon?
No public IPO plans have been announced for Immorna.
How can I track Immorna secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Immorna's secondary market activity and sign up for updates.